We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Fujisawa Healthcare and Roche Pharmaceuticals announced a partnership for the
U.S. co-promotion of MYCAMINE (micafungin sodium) injection, Fujisawa's newly
approved product for the treatment of patients with esophageal candidiasis and
for the propylaxis of Candida infections in patients undergoing hematopoietic
stem cell transplantation.
Dragon Pharmaceutical Inc. cut its annual loss for 2004 in half compared with
2003, helped by a recovery of $2.1 million that had earlier been written-off.
AXM Pharma, Inc. announced that it has signed a 2005 Distribution Agreement
for $483,676 with Beijing XinRenYou Medical Healthcare Co. Ltd for the company's
line of Anti-fatigue capsules products, Tong Yang, for distribution in Beijing.
Following recent reports that a number of multinational drug producers
have cautiously welcomed changes to the country's drug pricing structure, pharmacy
groups now appear divided on the issue.
A broad alliance of consumer groups, health professionals, trade
unions and local drugmakers has voiced support for a controversial new Brazilian
law enabling pharmacists to split up and repackage drug products.
Health authorities and drugmakers in Australia have agreed to a mandatory
12.5% price cut on new generic drugs, scheduled to come into effect tomorrow,
April 1.
Merrion Pharmaceuticals, Inc., a specialty pharmaceutical company with novel
approaches to oral drug delivery, is pleased to announce the issue of European
Patent Number EP1131344, "Retro-inversion peptides that target gastro-intestinal
tract transport receptors and related methods."